USD
$0.00
(0.00%
)At Close (As of Sep 12, 2025)
$138.37M
Market Cap
-
P/E Ratio
-3.11
EPS
$11.99
52 Week High
$5.47
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$25M |
Selling General And Administrative | $6.5M |
Research And Development | $19M |
Operating Expenses | $25M |
Investment Income Net | - |
Net Interest Income | $204K |
Interest Income | $222K |
Interest Expense | $19K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $2.1M |
Income Before Tax | -$27M |
Income Tax Expense | $800 |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$27M |
Comprehensive Income Net Of Tax | - |
Ebit | -$27M |
Ebitda | -$25M |
Net Income | -$27M |
Field | Value (USD) |
---|---|
Total Assets | $9.3M |
Total Current Assets | $9.2M |
Cash And Cash Equivalents At Carrying Value | $8.6M |
Cash And Short Term Investments | $8.6M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $111K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $566K |
Other Non Current Assets | - |
Total Liabilities | $9.2M |
Total Current Liabilities | $8.8M |
Current Accounts Payable | $1.9M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | - |
Total Non Current Liabilities | $412K |
Capital Lease Obligations | - |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $405K |
Other Current Liabilities | $6.9M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $104K |
Treasury Stock | - |
Retained Earnings | -$132M |
Common Stock | $20 |
Common Stock Shares Outstanding | $8.4M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$22M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | - |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | $28M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $485K |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$27M |
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$25M |
Selling General And Administrative | $6.5M |
Research And Development | $19M |
Operating Expenses | $25M |
Investment Income Net | - |
Net Interest Income | $204K |
Interest Income | $222K |
Interest Expense | $19K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $2.1M |
Income Before Tax | -$27M |
Income Tax Expense | $800 |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$27M |
Comprehensive Income Net Of Tax | - |
Ebit | -$27M |
Ebitda | -$25M |
Net Income | -$27M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None